SYNCHRON® LX20 PRO CLINICAL SYSTEM
Report
- Report Number
- 2050012-2010-00033
- Event Type
- Malfunction
- Date Received
- February 4, 2010
- Date of Event
- January 11, 2010
- Report Date
- February 4, 2010
- Manufacturer
- BECKMAN COULTER INC.
- Product Code
- JJE
- PMA / PMN Number
- K965240
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
UPON TROUBLESHOOTING THE CUSTOMER DISCOVERED THE REAGENT SYRINGE WAS LOOSE WHERE IT CONNECTS TO THE T-VALVE. PER CUSTOMER, MAINTENANCE TO THESE PARTS HAD NOT BEEN PERFORMED RECENTLY. SERVICE REPLACED THE SYRINGE AND THE T-VALVE. UPON RECUR, THE ISSUE COULD AFFECT OTHER CHEMISTRIES INCLUDING POTENTIALLY PIVOTAL CHEMISTRIES, AND TREATMENT COULD BE INITIATED OR WITHHELD BASED UPON THE ERRONEOUS RESULT. A CLEAR ROOT CAUSE IS NOT KNOWN AT THIS TIME. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.
A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING A SUPPRESSED MAGNESIUM (MG) RESULT GENERATED BY THE SYNCHRON LX20 PRO CLINICAL SYSTEM. THE INITIAL "SUPPRESSED OIR LO" MG RESULT WAS INTERPRETED TO BE <0.1 MG/DL AND REPORTED OUT AS 0.1 MG/DL. THE SPECIMEN WAS TESTED ON A DIFFERENT INSTRUMENT AND OBTAINED RESULT WAS "SUPPRESSED OIR HI". THE SPECIMEN WAS DILUTED 1:2, AND THEN RETESTED AND MG RESULT WAS 7.8 MG/DL (INSTRUMENT UNKNOWN) THE PATIENT WAS REDRAWN AND THE SAMPLE WAS TESTED ON THE LX20 ANALYZER WHICH GENERATED A "SUPPRESSED OIR HI" RESULT. THE REDRAWN SAMPLE WAS DILUTED 1:3 AND RE-TESTED, AND A RESULT OF 8.1 MG/DL WAS GENERATED. (INSTRUMENT UNKNOWN) THE RESULT WAS AMENDED. THERE WAS NO EFFECT TO THE PATIENT. THE ERRONEOUS RESULT WAS FOR A LABORING PATIENT RECEIVING A MG DRIP, AND THE LOW RESULT WAS NOT BELIEVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SYNCHRON® LX20 PRO CLINICAL SYSTEM | CLINICAL CHEMISTRY ANALYZER | JJE | BECKMAN COULTER INC. | LX20 PRO |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |